• Opinion
• [Editor’s View] Why still linger on bioequivalence test?
• by Chon, Seung-Hyun Oct 19, 2020 06:19am

• Opinion
• [Reporter's View] Vaccine's Cold Chain& Distribution System
• by Oct 17, 2020 06:36am

• Opinion
• [Reporter’sView] Revisiting gene list for NGS panel testing
• by Eo, Yun-Ho Oct 12, 2020 06:16am

• Opinion
• [Reporter’s view] Nikola and Korean Pharmaceutical Market
• by Kim, Jin-Gu Sep 28, 2020 06:21am

• Opinion
• [Reporter’s Note] Will KRPIA appoint a Korean chairman?
• by Eo, Yun-Ho Sep 21, 2020 06:12am

• Opinion
• [Reporter’s Note] “Loonshots” in new drug development
• by An, Kyung-Jin Sep 18, 2020 06:30am

• Opinion
• [Reporter’s View] A salesperson who lost a place to go
• by Kim, Jin-Gu Sep 4, 2020 06:52am

• Opinion
• [Reporter’s Note] Why so cautious with all-comers drug?
• by Eo, Yun-Ho Aug 27, 2020 06:24am

• Opinion
• [Reporter's view] Strategies for Trial & error/the evolution
• by An, Kyung-Jin Aug 25, 2020 06:14am

• Opinion
• [Reporter’s Note] Clinical trial info, do we have enough?
• by Lee, Tak-Sun Aug 21, 2020 06:26am